TY - JOUR
T1 - Role of integrin αvβ3 in the early phase of liver metastasis
T2 - PET and IVM analyses
AU - Kikkawa, Hironori
AU - Kaihou, Masako
AU - Horaguchi, Natsuko
AU - Uchida, Takayuki
AU - Imafuku, Hidetoshi
AU - Takiguchi, Ayano
AU - Yamazaki, Yukako
AU - Koike, Chieko
AU - Kuruto, Ryoko
AU - Kakiuchi, Takeharu
AU - Tsukada, Hideo
AU - Takada, Yoshikazu
AU - Matsuura, Nariaki
AU - Oku, Naoto
PY - 2002
Y1 - 2002
N2 - To clarify the function of integrin αvβ3 in the early stage of liver metastasis, we investigated the interactions of metastatic cells with their target organ under the actual blood flow by using positron emission tomography (PET). The cells used were CHO-K1 cells and their transfectants bearing human integrin αvβ3 cDNA (αvβ3-CHO-K1 cells). The liver accumulation of αvβ3-CHO-K1 cells was significantly higher than that of CHO-K1 cells after injection via the portal vein, whereas no significant difference was observed in the lung accumulation after tail vein injection, suggesting a specific interaction of αvβ3-CHO-K1 cells with the hepatic sinusoids. Furthermore, to clarify the precise location of each cell in the liver, i.e., to determine whether individual cells were intravascularly localized or had extravasated, we performed intravital fluorescence microscopy (IVM) on the liver by using stable transfectants bearing the green fluorescent protein (GFP) gene, namely, GFP-CHO-K1 and GFP-αvβ3-CHO-K1 cells. Both types of cells remained in the hepatic blood vessels 1 h after injection via the portal vein. On the other hand, expression of integrin αvβ3 promoted the cells to reach the extravascular region after 24 h. These results suggest the possibility that the specific accumulation of αvβ3-CHO-K1 cells in the liver is followed by migration of the cells into the extravascular region. Interestingly, the adhesion of the two types of cells to hepatic sinusoidal endothelial cells in vitro did not correspond to in vivo accumulation of these cells. Therefore, integrin αvβ3 may function to promote extravasation of integrin αvβ3-expressing tumor cells in liver through a process possibly mediated by vitronectin produced by this organ.
AB - To clarify the function of integrin αvβ3 in the early stage of liver metastasis, we investigated the interactions of metastatic cells with their target organ under the actual blood flow by using positron emission tomography (PET). The cells used were CHO-K1 cells and their transfectants bearing human integrin αvβ3 cDNA (αvβ3-CHO-K1 cells). The liver accumulation of αvβ3-CHO-K1 cells was significantly higher than that of CHO-K1 cells after injection via the portal vein, whereas no significant difference was observed in the lung accumulation after tail vein injection, suggesting a specific interaction of αvβ3-CHO-K1 cells with the hepatic sinusoids. Furthermore, to clarify the precise location of each cell in the liver, i.e., to determine whether individual cells were intravascularly localized or had extravasated, we performed intravital fluorescence microscopy (IVM) on the liver by using stable transfectants bearing the green fluorescent protein (GFP) gene, namely, GFP-CHO-K1 and GFP-αvβ3-CHO-K1 cells. Both types of cells remained in the hepatic blood vessels 1 h after injection via the portal vein. On the other hand, expression of integrin αvβ3 promoted the cells to reach the extravascular region after 24 h. These results suggest the possibility that the specific accumulation of αvβ3-CHO-K1 cells in the liver is followed by migration of the cells into the extravascular region. Interestingly, the adhesion of the two types of cells to hepatic sinusoidal endothelial cells in vitro did not correspond to in vivo accumulation of these cells. Therefore, integrin αvβ3 may function to promote extravasation of integrin αvβ3-expressing tumor cells in liver through a process possibly mediated by vitronectin produced by this organ.
KW - Cell trafficking
KW - Integrin αvβ3
KW - Liver metastasis
KW - PET
UR - http://www.scopus.com/inward/record.url?scp=0036943691&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0036943691&partnerID=8YFLogxK
U2 - 10.1023/A:1021356019563
DO - 10.1023/A:1021356019563
M3 - Article
C2 - 12553378
AN - SCOPUS:0036943691
SN - 0262-0898
VL - 19
SP - 717
EP - 725
JO - Clinical and Experimental Metastasis
JF - Clinical and Experimental Metastasis
IS - 8
ER -